Krystal Biotech Inc.
Company Snapshot
Founded: 2015
Entity Type: Public
Employees: 275
Region: U.S.
Revenue: $290.5 Millions
Revenue Year: 2024
Headquarter: Pennsylvania, U.S.
Key Geographics: North America, Europe
Corporate Address: 2100 Wharton Sreet Suite #310 Pittsburgh 15203 Pennsylvania U.S. Tel. +1-412-586-5830 www.krystalbio.com
Company Overview
Krystal Biotech concentrates on the development and commercialization of genetic medicines tailored for individuals with rare diseases. The company's pipeline relies on its exclusive redosable HSV vector. The company has capabilities in viral vector design, vector optimization, gene therapy manufacturing, and the commercialization of these therapies.
Financial Highlights (FY 2024)
Net Revenue: ***
Total Current Liabilities: ***
Total Current Assets: ***
R&D expenses: ***
Operating Income: ***
This information is available for BCC Research members only.
Company's Business Segments
- Gene Therapy : The company provides genetic medicines by utilizing revocable gene therapies to treat severe, life‑threatening, and rare diseases with limited or non-approved therapies.
Applications/End User Industries
- Healthcare
- Pharmaceuticals
- Biotechnology
BCC Research Beacon 